RT Journal Article
SR Electronic
T1 A multiethnic GWAS meta-analysis of 585,243 individuals identifies new risk loci associated with cataract and reveals sex-specific effects
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.23.20200428
DO 10.1101/2020.09.23.20200428
A1 Choquet, Hélène
A1 Melles, Ronald B.
A1 Anand, Deepti
A1 Yin, Jie
A1 Cuellar-Partida, Gabriel
A1 Wang, Wei
A1 ,
A1 Hoffmann, Thomas J.
A1 Nair, K Saidas
A1 Hysi, Pirro G.
A1 Lachke, Salil A.
A1 Jorgenson, Eric
YR 2020
UL http://medrxiv.org/content/early/2020/09/24/2020.09.23.20200428.abstract
AB Cataract is the leading cause of blindness among the elderly worldwide and cataract surgery is one of the most common operations performed in the United States1-3. The etiology remains largely unclear, and to contribute to its elucidation we conducted a multiethnic genome-wide association meta-analysis of cataract, combining results from the GERA and UK Biobank cohorts, and tested for replication in the research cohort from 23andMe, Inc.. We report 54 genome-wide significant loci, 37 of which were previously unknown. Sex-stratified analyses identified two additional novel loci (CASP7 and GSTM2) specific to women and sex differences in effect sizes and significance of association at five other loci. We show that genes within or near 80% of the cataract-associated loci are significantly expressed and/or enriched-expressed in the mouse lens across various spatiotemporal stages. Further, 32 candidate genes in the associated loci have altered gene expression in 9 different gene perturbation mouse models of lens defects/cataract, suggesting their relevance to lens biology.Competing Interest StatementGabriel Cuellar Partida and Wei Wang are employed by and hold stock or stock options in 23andMe, Inc. The other authors declare no competing financial or non-financial interests.Funding StatementSupport for participant enrollment, survey completion, and biospecimen collection for the RPGEH was provided by the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, and Kaiser Permanente Community Benefit Programs. Genotyping of the GERA cohort was funded by a grant from the National Institute on Aging, National Institute of Mental Health, and National Institute of Health Common Fund (RC2 AG036607). H.C. and E.J. were supported by the National Eye Institute (NEI) grant R01 EY027004, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK116738 and by the National Cancer Institute (NCI) R01CA2416323. This work was also made possible in part by NIH-NEI EY002162-Core Grant for Vision Research, by the Research to Prevent Blindness Unrestricted Grant (UCSF, Ophthalmology). K.S.N. receives support from NEI grant EY022891, BrightFocus Foundation (G2019360), Marin Community Foundation-Kathlyn McPherson Masneri and Arno P. Masneri Fund, and That Man May See Inc. T.J.H. was supported by National Institutes of Aging (NIA) grant R21 AG046616. S.A.L. was supported by National Institutes of Health / National Eye Institute grants R01 EY021505 and EY029770 and D.A. was supported by a Knights Templar Pediatric Ophthalmology Career Starter Grant Award.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study procedures were approved by the Institutional Review Board of the Kaiser Permanente Northern California Institutional Review Board. Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe GERA genotype data are available upon application to the KP Research Bank (https://researchbank.kaiserpermanente.org/). The combined (GERA+UKB) meta-analysis GWAS summary statistics are available from the NHGRI-EBI GWAS Catalog (https://www.ebi.ac.uk/gwas/downloads/summary-statistics). The variant-level data for the 23andMe replication dataset are fully disclosed in the manuscript. Individual-level data are not publicly available due participant confidentiality, and in accordance with the IRB-approved protocol under which the study was conducted.